個性化癌症檢測
為您提供精確護理

個性化精準護理，因為您的治療應該與您一樣獨特

立即探索您的選擇！

想知道您是否容易有癌症風險？

試試這個3分鐘免費癌症風險評估

關於我們

在 RGCC，我們擁有 20 多年精準的醫學專業知識，為您提供度身定製的護理。我們的個人化檢測會針對導致癌症的致癌基因，來制定對抗癌症或增強免疫系統的策略。我們的敏感性測試可確定哪些藥物和天然物質最適合您，從而確保制定有效的訂製治療計劃。
每一次癌症之旅都是獨一無二的。我們會以同理心協助您，提供明確的方向，並根據您的需求專注地提供安全、有針對性的解決方案。

您的護理夥伴
在 RGCC，我們在您的整個旅程中與您同在。憑藉個性化的護理、尖端研究和敬業的團隊，我們會令您自信地邁向更健康的未來。

我們如何支持您：

創新研究：為您帶來最新突破來幫助您。

個性化測試：度身訂制以識別您身體最需要的東西。

精準醫療：制定切合您的癌症的獨特治療計劃。

瑞士頂尖生物科技公司 2023

我們很高興宣布RGCC在 2023 年獲《生物科學評論》評選為十大瑞士生物科技公司之一，是一份非常卓越的認可。能夠與瑞士的生技領導者並肩而立，證明了我們對創新、卓越的堅定承諾，以及我們對生命科學領域的持續貢獻。

在 RGCC 的一切工作中，我們由始至終只考慮：病人

每個人都是獨特的。為什麼他們的癌症要是一模一樣的？為什麼每個人都應該用相同方式接受一樣的治療？

Dr Ioannis Papasotiriou

RGCC總監, International GmbH

RGCC 測試和療法旨在解決複雜性，提供清晰度並推動癌症護理的界限。

每位癌症患者需要知道的事情

癌症治療不僅僅是化療
每種癌症都是獨特的
即使在同一個器官中，沒有兩種癌症是相同的
有效治療癌症的關鍵在於個性化的方法。
這種複雜的疾病需要一個有能力的策略，評估涉及查看一個人的基因、身體機能和免疫狀況。
實時的深入了解是必要的，而不是奢侈的。

在每一步，每一階段，
我們都與您同在！

Screening test

Onco-D-clare

Clinically validated and with a high accuracy of ≈93%, this screening test can help detect cancer before symptoms appear. The test is a cancer screening test based on the interaction of molecular biology with machine learning algorithms.

Supportive Tests

ChemoSNiP

Using an advanced scientific technique called pharmacogenomics, this innovative test analyzes how a patient’s body will respond to a specific drug. It provides clinicians with a powerful insight into which drugs are most effective at treating cancer.

ArrayCGH

Helping clinicians to understand more about a patient’s genes, the test serves as a powerful tool in the fight against cancer. It identifies chromosomal abnormalities in a patient that could lead to cancer.

Immune-Frame

Assessing specific cellular markers responsible for activating or suppressing an immune system, the test provides the status of a patient’s immune system and ongoing information about their health. It helps plan their treatment and to determine which therapy is appropriate.

Metastat

Suitable for all patients who have received a confirmed cancer diagnosis, this advanced test that detects specific blood-borne markers can accurately determine whether a secondary cancerous tumor is likely to develop and its potential location.

Comprehensive tests

Onconomics

The test determines the most effective chemotherapeutic agent for you by assessing the efficacy of specific cancer drugs and targeted therapies. It helps create an individualized profile for the effectiveness of various chemotherapeutic substances on your cancer cells.

Onconomics Plus

The most comprehensive testing tool to help build personalized cancer treatment protocols for patients. The test returns information crucial for devising individualized treatment plans for each patient.

Onconomics Extracts

A unique and highly detailed test that provides information on how effective natural substances and plant extracts are at tackling circulating tumor cells (CTCs). It uses three unique and scientifically proven methods to assess this information.

Onconomics Extracts Plus

The test provides highly detailed and accurate information about how effective specific natural substances and plant extracts are, as anticancer agents. By offering more insight into the gene expressions of your cancer cells, it clarifies how the cancer behaves within your body.

Follow-up tests

Oncocount

Being a vital tool to check the presence of CTCs, the test assesses how effective cancer treatment is and the likelihood of cancer returning (relapse) thus serving as a monitoring tool.

Oncotrace

The test aids in identifying the unknown origin of a tumor and provides information on the development of cancer and the prognosis by evaluating CTC count. It plays a vital role in monitoring treatment progression by providing much crucial information

Oncotrail

The test provides essential information on the effectiveness of current cancer treatments focused on your specific type of cancer. It is a tailored test which gives information about your specific cancer.

Next-Generation Sequencing

CAMBISeq

Suitable for all patients who have a confirmed cancer diagnosis, the test helps identify the best, and most effective, combinations of cancer treatments. It is an innovative test that uses next-generation sequencing analysis on both DNA and RNA to provide clinicians with crucial insight into cancer.